M. Adimy, A. Chekroun, and T. M. Touaoula, Age-Structured and Delay Differential-Difference Model Of Hematopoietic Stem Cell Dynamics, Discret And Continuous Dynamical Systems Series B, pp.2765-2791, 2015.

M. Adimy, F. Crauste, and A. Abdllaoui, DISCRETE-MATURITY STRUCTURED MODEL OF CELL DIFFERENTIATION WITH APPLICATIONS TO ACUTE MYELOGENOUS LEUKEMIA, Journal of Biological Systems, vol.92, issue.03, pp.395-424, 2008.
DOI : 10.1046/j.1365-2141.1999.01168.x
URL : https://hal.archives-ouvertes.fr/hal-00750276

J. L. Avila, C. Bonnet, J. Clairambault, H. Özbay, S. Niculescu et al., Analysis of a New Model of Cell Population Dynamics in Acute Myeloid Leukemia, «Delay Systems : From Theory to Numerics and Applications», Advances in Delays and Dynamics, pp.315-328, 2014.
DOI : 10.1007/978-3-319-01695-5_23
URL : https://hal.archives-ouvertes.fr/hal-00932779

H. M. Blau, T. R. Brazelton, and J. M. Weimann, The Evolving Concept of a Stem Cell, Cell, vol.105, issue.7, pp.829-841, 2001.
DOI : 10.1016/S0092-8674(01)00409-3

W. Djema, F. Mazenc, and C. Bonnet, Stability analysis and robustness results for a nonlinear system with distributed delays describing hematopoiesis, Systems & Control Letters, vol.102, pp.93-101, 2017.
DOI : 10.1016/j.sysconle.2017.01.007
URL : https://hal.archives-ouvertes.fr/hal-01627125

W. Djema, F. Mazenc, C. Bonnet, J. Clairambault, P. Hirsch et al., Stability of a Delay System Coupled to a Delay Differential-Difference System Describing the Coexistence of Ordinary and Mutated Hematopoietic Stem cells, the 55 th Conference on Decision and Control, 2016.

H. Döhner, D. J. Weisdorf, and C. D. Bloomfield, Acute Myeloid Leukemia, New England Journal of Medicine, vol.373, issue.12, pp.1136-1152, 2015.
DOI : 10.1056/NEJMra1406184

T. Enver, M. Pera, C. Peterson, and P. W. Andrews, Stem Cell States, Fates, and the Rules of Attraction, Cell Stem Cell, vol.4, issue.5, pp.387-397, 2009.
DOI : 10.1016/j.stem.2009.04.011

]. C. Foley and M. C. Mackey, Dynamic hematological disease: a review, Journal of Mathematical Biology, vol.89, issue.3, pp.285-322, 2009.
DOI : 10.1111/j.1600-0609.1986.tb02283.x

C. Foley, S. Bernard, and M. C. Mackey, Cost-effective G-CSF therapy strategies for cyclical neutropenia: Mathematical modelling based hypotheses, Journal of Theoretical Biology, vol.238, issue.4, pp.754-763, 2006.
DOI : 10.1016/j.jtbi.2005.06.021
URL : https://hal.archives-ouvertes.fr/hal-00542529

E. Fridman, C. Bonnet, F. Mazenc, and W. Djema, Stability of the cell dynamics in acute myeloid leukemia, Systems & Control Letters, vol.88, pp.91-100, 2016.
DOI : 10.1016/j.sysconle.2015.09.006
URL : https://hal.archives-ouvertes.fr/hal-01257577

R. Hoffman, E. J. Benz, L. E. Silberstein, H. Heslop, J. Weitz et al., Hematology: Basic Principles and Practice, 2012.

G. Jansen, R. Gatenby, and C. A. , Aktipis, Control vs. eradication: Applying infectious disease treatment strategies to cancer, Proceedings of the National Academy of Sciences of United States of America, pp.937-938, 2015.

I. Kareva, Primary and metastatic tumor dormancy as a result of population heterogeneity, Biology Direct, vol.46, issue.7, 2016.
DOI : 10.1016/j.ejca.2010.02.027

E. Lainey, S. Thépot, C. Bouteloup, M. Sébert, L. Adès et al., Tyrosine kinase inhibitors for the treatment of acute myeloid leukemia: Delineation of anti-leukemic mechanisms of action, Biochemical Pharmacology, vol.82, issue.10, pp.1457-1466, 2011.
DOI : 10.1016/j.bcp.2011.05.011

J. D. Logan, Applied Partial Differential Equations, Undergraduate Texts in Mathematics, 2015.

A. G. Mckendrick, Applications of Mathematics to Medical Problems, Proceedings of the Edinburgh Mathematical Society 44, pp.98-130, 1925.
DOI : 10.1038/104660a0

M. C. Mackey, Unified hypothesis of the origin of plastic anemia and periodic hematopoiesis, Blood, vol.51, pp.941-956, 1978.

A. Marciniak-czochra, T. Stiehl, A. D. Ho, W. Jäger, and W. Wagner, Modeling of asymmetric cell division in hematopoietic stem cells-regulation of self-renewal is essential for efficient repopulation, Stem cells and development 18, pp.377-386, 2009.

D. Morgan, The Cell Cycle: Principles of Control, Primers in Biology Series, p.297, 2006.

G. N. Naumov, J. Folkman, and O. Straume, Tumor dormancy due to failure of angiogenesis: role of the microenvironment, Clinical & Experimental Metastasis, vol.10, issue.3, pp.51-60, 2009.
DOI : 10.1091/mbc.12.4.863

M. Nielsen, J. Thomsen, S. Primdahl, U. Dyreborg, and J. Andersen, Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies, British Journal of Cancer, vol.56, issue.6, pp.814-823, 1987.
DOI : 10.1038/bjc.1987.296

H. Özbay, C. Bonnet, H. Benjelloun, and J. Clairambault, Stability Analysis of Cell Dynamics in Leukemia, Mathematical Modelling of Natural Phenomena, vol.213, issue.2, pp.203-234, 2012.
DOI : 10.1002/jcp.21140

E. Passegué, C. H. Jamieson, L. E. Ailles, and I. L. Weissman, Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?, Proc. Natl. Acad. Sci., Regenerative Medicine, pp.11842-11849, 2003.
DOI : 10.1073/pnas.2034201100

E. Pronier and F. Delhommeau, Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors, Blood, vol.118, issue.9, pp.2551-2555, 2011.
DOI : 10.1182/blood-2010-12-324707

L. Pujo-menjouet, S. Bernard, and M. C. Mackey, Model of Hematopoietic Stem Cells, SIAM Journal on Applied Dynamical Systems, vol.4, issue.2, pp.312-332, 2005.
DOI : 10.1137/030600473

D. B. Sykes, Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia, Cell, vol.167, issue.1, pp.171-186, 2016.
DOI : 10.1016/j.cell.2016.08.057

K. P. Wilkie and P. , Tumor-Immune Dynamics Regulated in the Microenvironment Inform the Transient Nature of Immune-Induced Tumor Dormancy, Cancer Research, vol.73, issue.12, pp.3534-3578, 2013.
DOI : 10.1158/0008-5472.CAN-12-4590

P. P. Zarrinkar, AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML), Blood, vol.114, issue.14, pp.2984-2992, 2009.
DOI : 10.1182/blood-2009-05-222034